Ghasemi Nazem, Razavi Shahnaz, Nikzad Elham
Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Jesus Son of Mary Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Cell J. 2017 Apr-Jun;19(1):1-10. doi: 10.22074/cellj.2016.4867. Epub 2016 Dec 21.
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) lesions that can lead to severe physical or cognitive disability as well as neurological defects. Although the etiology and pathogenesis of MS remains unclear, the present documents illustrate that the cause of MS is multifactorial and include genetic predisposition together with environmental factors such as exposure to infectious agents, vitamin deficiencies, and smoking. These agents are able to trigger a cascade of events in the immune system which lead to neuronal cell death accompanied by nerve demyelination and neuronal dysfunction. Conventional therapies for MS are based on the use of anti-inflammatory and immunomodulatory drugs, but these treatments are not able to stop the destruction of nerve tissue. Thus, other strategies such as stem cell transplantation have been proposed for the treatment of MS. Overall, it is important that neurologists be aware of current information regarding the pathogenesis, etiology, diagnostic criteria, and treatment of MS. Thus, this issue has been discussed according to recent available information.
多发性硬化症(MS)是一种慢性炎症性疾病,其特征是中枢神经系统(CNS)病变,可导致严重的身体或认知残疾以及神经功能缺陷。尽管MS的病因和发病机制尚不清楚,但现有文献表明,MS的病因是多因素的,包括遗传易感性以及环境因素,如接触传染原、维生素缺乏和吸烟。这些因素能够在免疫系统中引发一系列事件,导致神经元细胞死亡,并伴有神经脱髓鞘和神经元功能障碍。MS的传统治疗方法基于使用抗炎和免疫调节药物,但这些治疗方法无法阻止神经组织的破坏。因此,已提出其他策略,如干细胞移植,用于治疗MS。总体而言,神经科医生了解有关MS发病机制、病因、诊断标准和治疗的当前信息非常重要。因此,根据最近可获得的信息对这个问题进行了讨论。